PLX Earnings

Quarterly EPS
$-0.03
Q2 2024
$0.04
Q3 2024
$0.09
Q4 2024
$-0.05
Q1 2025
$0.00
Q2 2025
$0.03
Q3 2025
$-0.07
Q4 2025
$0.23
Q1 2026
Latest Revenue33.8M
Latest Net Income18.3M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2026$0.2333.8M18.3M+233.7%+560.0%
Q4 2025-$0.079.1M-5504000-49.9%-177.8%
Q3 2025$0.0317.9M2.4M-0.6%-25.0%
Q2 202515.7M164.0K+16.2%
Q1 2025-$0.0510.1M-3619000+169.8%+16.7%
Q4 2024$0.0918.2M6.5M+73.7%+212.5%
Q3 2024$0.0418.0M3.2M+73.6%+233.3%
Q2 2024-$0.0313.5M-2203000-61.6%-110.3%
Q1 2024-$0.063.7M-4595000
Q4 2023-$0.0810.5M-6044000
Q3 2023-$0.0310.3M-1852000
Q2 2023$0.2935.1M19.3M
Protalix BioTherapeutics (PLX) — Earnings